GI CANCERS SYMPOSIUM 2024 ROUNDTABLE DISCUSSION: EMERALD-1
OR
Chair
Dr. Scott Berry
Panelists
Dr. Sharlene Gill
Prof. Marc Peeters
This program has been made possible through unrestricted support from Amgen & Advanced Accelerator Applications
Studies/trials discussed:
- Emerald 1 Study
- The value of systemic therapy in combination with taste for patient with intermediate stage hepatocellular carcinoma
